Candriam SCA’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Candriam SCA’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Hold	1,132,563	–	–	0.01%	502
2026 Q1	$2.79M	Hold	1,132,563	–	–	0.01%	466
2025 Q4	$4.51M	Hold	1,132,563	–	–	0.02%	387
2025 Q3	$4.28M	Hold	1,132,563	–	–	0.02%	392
2025 Q2	$2.74M	Buy	+1,132,563	New	+$1.54M	0.02%	448
2020 Q3	–	Sell	-32,624	Closed	-$977K	–	816
2020 Q2	$977K	Buy	+32,624	New	+$675K	0.01%	601

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Candriam SCA's NBP Position: Q2 2026 in Review

Candriam SCA held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 1,132,563 shares worth $2.21M. The position accounts for 0.01% of the portfolio, ranked #502.

Candriam SCA first reported a position in NBP in Q2 2020 and has held it in 6 quarters since. The position peaked at $4.51M in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Candriam SCA held 1,132,563 shares of NovaBridge Biosciences American Depositary Shares worth $2.21M as of Q2 2026.
Candriam SCA left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #502 holding.
Candriam SCA first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 6 quarters since.
Candriam SCA's NovaBridge Biosciences American Depositary Shares position peaked at $4.51M in Q4 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.